Table of Contents
Cough, Cold and Allergy (hay Fever) Remedies in Egypt
Euromonitor
International
June 2009
List of Contents and Tables
Executive
Summary
Dynamic Growth in OTC Healthcare in Egypt
the Rigid Control of
the Ministry of Health Is A Constraint To Sales
Egyptian Companies and
Multinationals Compete for Market Share
Distribution Is Only Allowed
Through Chemists/pharmacies
A Bright Forecast for OTC Healthcare
Key
Trends and Developments
Rigid Control by the Ministry of Health Over the
OTC Healthcare Market
Low Purchasing Power Hinders Sales of OTC Healthcare
Products
Strike of Chemists/pharmacies at the Beginning of 2009
Lack
of Awareness of Brands in the Market
Market Indicators
Table 1
Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table
2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC
Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by
Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by
Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis
2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution
Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by
Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by
Sector: % Value Growth 2008-2013
Appendix
OTC Registration and
Classification
Vitamins & Dietary Supplements Registration and
Classification
Self-medication and Preventative Medicine
Generics
Definitions
Summary 1 Research Sources
Amoun Pharmaceutical Industry
Co
Strategic Direction
Key Facts
Summary 2 Amoun Pharmaceutical
Industry Co: Key Facts
Company Background
Production
Competitive
Positioning
Summary 3 Amoun Pharmaceutical Industry Co: Competitive
Position 2008
Atos Pharma
Strategic Direction
Key Facts
Summary 4 Atos Pharma: Key Facts
Company Background
Production
Competitive Positioning
Summary 5 Atos Pharma: Competitive Position
2008
Egyptian International Pharmaceutical Industries Co Sae (eipico)
Strategic Direction
Key Facts
Summary 6 Egyptian International
Pharmaceutical Industries Co SAE (EIPICO): Key Facts
Company
Background
Production
Competitive Positioning
Summary 7 Egyptian
International Pharmaceutical Industries Co SAE (EIPICO): Competitive Position
2008
Kahira Pharmaceutical & Chemical Industries Co
Strategic
Direction
Key Facts
Summary 8 Kahira Pharmaceutical & Chemical
Industries Co: Key Facts
Company Background
Production
Competitive
Positioning
Summary 9 Kahira Pharmaceutical & Chemical Co: Competitive
Position 2008
Pharco Pharmaceuticals
Strategic Direction
Key
Facts
Summary 10 Pharco Pharmaceuticals: Key Facts
Company
Background
Production
Competitive Positioning
Summary 11 Pharco
Pharmaceuticals: Competitive Position 2008
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of
Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: %
Value Growth 2003-2008
Table 13 Sales of Decongestants by Type: Value
2003-2008
Table 14 Sales of Decongestants by Type: % Value Growth
2003-2008
Table 15 Sales of Child-specific Cough, Cold and Allergy (Hay
Fever) Remedies by Type: Value 2003-2008
Table 16 Sales of Child-specific
Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth
2003-2008
Table 17 Herbal vs Standard Cough, Cold and Allergy (Hay Fever)
Remedies 2003-2008
Table 18 Cough, Cold and Allergy (Hay Fever) Remedies
Company Shares by Value 2004-2008
Table 19 Cough, Cold and Allergy (Hay
Fever) Remedies Brand Shares by Value 2005-2008
Table 20 Forecast Sales of
Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: % Value Growth 2008-2013
| 
View Cart
